Wordt geladen...
Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy
Introduction and Objectives. Neutrophil-to-lymphocyte ratio (NLR) has been suggested to be a simple marker of the systemic inflammatory response in critical care patients. We previously assessed the utility of NLR as a biomarker to predict tumor recurrence and cancer death in bladder cancer patients...
Bewaard in:
| Gepubliceerd in: | Biomed Res Int |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi Publishing Corporation
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5086366/ https://ncbi.nlm.nih.gov/pubmed/27822480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/9846823 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|